DE69631141D1 - Biologisch aktive peptide und ihre zubereitungen und verwendungen - Google Patents
Biologisch aktive peptide und ihre zubereitungen und verwendungenInfo
- Publication number
- DE69631141D1 DE69631141D1 DE69631141T DE69631141T DE69631141D1 DE 69631141 D1 DE69631141 D1 DE 69631141D1 DE 69631141 T DE69631141 T DE 69631141T DE 69631141 T DE69631141 T DE 69631141T DE 69631141 D1 DE69631141 D1 DE 69631141D1
- Authority
- DE
- Germany
- Prior art keywords
- preparations
- biologically active
- active peptides
- derivatives
- geodiamolide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9508195 | 1995-04-20 | ||
GBGB9508195.6A GB9508195D0 (en) | 1995-04-20 | 1995-04-20 | Novel biologically active compounds and compositions,their use and derivation |
PCT/GB1996/000942 WO1996033211A1 (en) | 1995-04-20 | 1996-04-22 | Biologically active peptides and compositions, their use |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69631141D1 true DE69631141D1 (de) | 2004-01-29 |
DE69631141T2 DE69631141T2 (de) | 2004-09-30 |
Family
ID=10773352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69631141T Expired - Lifetime DE69631141T2 (de) | 1995-04-20 | 1996-04-22 | Biologisch aktive peptide und ihre zubereitungen und verwendungen |
Country Status (12)
Country | Link |
---|---|
US (4) | US6153590A (de) |
EP (1) | EP0839154B1 (de) |
JP (2) | JP4008493B2 (de) |
AT (1) | ATE256698T1 (de) |
AU (1) | AU5341696A (de) |
CA (1) | CA2220021C (de) |
DE (1) | DE69631141T2 (de) |
DK (1) | DK0839154T3 (de) |
ES (1) | ES2213173T3 (de) |
GB (1) | GB9508195D0 (de) |
PT (1) | PT839154E (de) |
WO (1) | WO1996033211A1 (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2225325A1 (en) * | 1997-12-19 | 1999-06-19 | The University Of British Columbia | Hemiasterlin analogs |
CA2360740A1 (en) | 1999-03-02 | 2000-09-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compounds useful as reversible inhibitors of cathepsin s |
MY164077A (en) * | 1999-05-13 | 2017-11-30 | Pharma Mar Sa | Compositions and uses of et743 for treating cancer |
US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
MXPA02011319A (es) * | 2000-05-15 | 2003-06-06 | Pharma Mar Sa | Analogos antitumorales de ecteinascidina 743. |
CA2428160C (en) * | 2000-11-06 | 2009-10-13 | Pharma Mar, S.A. | Compositions for antitumor treatment containing ecteinascidin 743 |
GB0202544D0 (en) * | 2002-02-04 | 2002-03-20 | Pharma Mar Sa | The synthesis of naturally occuring ecteinascidins and related compounds |
EP2374454B1 (de) * | 2002-03-22 | 2016-05-11 | Eisai R&D Management Co., Ltd. | Hemiasterlin-derivate und deren verwendung in der behandlung von krebs |
US7064211B2 (en) * | 2002-03-22 | 2006-06-20 | Eisai Co., Ltd. | Hemiasterlin derivatives and uses thereof |
US20040121965A1 (en) * | 2002-09-20 | 2004-06-24 | Wyeth Holdings Corporation | Method of treating resistant tumors |
MXPA05002874A (es) * | 2002-09-20 | 2005-05-27 | Wyeth Corp | Procedimiento para la sintesis de intermediarios utiles para la sintesis de inhibidores de tubulina. |
PT1558354E (pt) * | 2002-10-30 | 2010-04-20 | Merck Sharp & Dohme | Utilização de aminas, aminoácidos ou ésteres de aminoácidos como modificadores da fase móvel em cromatografia |
AU2003295808A1 (en) * | 2002-11-21 | 2004-06-18 | Wyeth | Hemiasterlin affinity probes and their uses |
GB0312407D0 (en) * | 2003-05-29 | 2003-07-02 | Pharma Mar Sau | Treatment |
US7390910B2 (en) * | 2003-08-08 | 2008-06-24 | Wyeth | Compounds for treating tumors |
GB0324201D0 (en) * | 2003-10-15 | 2003-11-19 | Pharma Mar Sau | Improved antitumoral combinations |
DK1689404T3 (da) * | 2003-11-13 | 2009-01-26 | Pharma Mar Sau | Kombination af et-743 med 5-fluoracil-prodrugs til behandling af cancer |
WO2005049030A1 (en) * | 2003-11-14 | 2005-06-02 | Pharma Mar, S.A. | Combination therapy comprising the use of et-743 and paclitaxel for treating cancer |
GB0326486D0 (en) * | 2003-11-14 | 2003-12-17 | Pharma Mar Sau | Combination treatment |
WO2006005602A2 (en) * | 2004-07-09 | 2006-01-19 | Pharma Mar, S.A. | Use of ecteinascidin in the treatment of cancer in patients with low level of brca1 |
EP1812114A2 (de) * | 2004-09-29 | 2007-08-01 | Pharma Mar S.A., Sociedad Unipersonal | Ecteinascidin-zusammensetzungen als entzündungshemmende wirkstoffe |
NZ554765A (en) * | 2004-10-26 | 2010-01-29 | Pharma Mar Sa | Pegylated Liposomal Doxorubicin In Combination With Ecteinescidin 743 |
ATE368461T1 (de) * | 2004-10-29 | 2007-08-15 | Pharma Mar Sa | Zusammensetzungen enthaltend ecteinascidin und einen disaccharide |
EP1828776A4 (de) * | 2004-12-09 | 2010-03-17 | Eisai R&D Man Co Ltd | Tubulinisotypsuche bei der krebstherapie mit hemiasterlinanalogen |
AU2006244450A1 (en) * | 2005-05-05 | 2006-11-16 | Eisai Co., Ltd. | Unsolvated and host-guest solvated crystalline forms of (2E,4S)-4-[(N-{[(2R)-1-isopropylpiperidin-2-yl]-carbonyl}-3-methyl-L-valyl)(methyl)amino)-2,5-dimethylhex-2-enoic acid and their pharmaceutical uses |
GB0522082D0 (en) * | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
WO2008095004A2 (en) * | 2007-01-31 | 2008-08-07 | Affymax, Inc. | Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
AU2008313634A1 (en) * | 2007-10-19 | 2009-04-23 | Pharma Mar, S.A. | Prognostic molecular markers for ET-743 treatment |
JP5501251B2 (ja) | 2008-01-11 | 2014-05-21 | アルバニー モレキュラー リサーチ, インコーポレイテッド | Mch拮抗薬としての(1−アジノン)置換ピリドインドール類 |
US8629158B2 (en) | 2009-07-01 | 2014-01-14 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
US9073925B2 (en) | 2009-07-01 | 2015-07-07 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
US8618299B2 (en) | 2009-07-01 | 2013-12-31 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof |
US8637501B2 (en) | 2009-07-01 | 2014-01-28 | Albany Molecular Research, Inc. | Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof |
WO2012088124A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof |
WO2012088038A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof |
CN103570603A (zh) * | 2012-07-19 | 2014-02-12 | 杭州中肽生化有限公司 | 哈米特林的一种合成新方法 |
ES2741207T3 (es) | 2013-03-15 | 2020-02-10 | Zymeworks Inc | Compuestos citotóxicos y antimitóticos, y métodos de uso de los mismos |
PL3086815T3 (pl) | 2013-12-27 | 2022-06-13 | Zymeworks Inc. | Układy łącznikowe dla koniugatów leków zawierające ugrupowanie sulfonamidowe |
US10675355B2 (en) | 2013-12-27 | 2020-06-09 | Var2 Pharmaceuticals Aps | VAR2CSA-drug conjugates |
IL287645B2 (en) | 2014-09-17 | 2024-04-01 | Zymeworks Bc Inc | Cytotoxic and anti-mitotic compounds and methods for their use |
JP7011830B2 (ja) | 2015-10-14 | 2022-01-27 | エックス-サーマ インコーポレイテッド | 氷晶形成を低減するための組成物および方法 |
US10517958B2 (en) | 2016-10-04 | 2019-12-31 | Zymeworks Inc. | Compositions and methods for the treatment of platinum-drug resistant cancer |
PT3666787T (pt) | 2017-08-10 | 2024-03-21 | Sumitomo Pharma Co Ltd | Conjugados anticorpo-fármaco que incluem um derivado da hemiasterlina |
WO2019031615A1 (ja) * | 2017-08-10 | 2019-02-14 | 大日本住友製薬株式会社 | ヘミアスタリン誘導体及びこれらの抗体薬物複合体 |
US20220202948A1 (en) * | 2019-02-13 | 2022-06-30 | Sumitomo Dainippon Pharma Co., Ltd. | Agent for Eliminating Pluripotent Stem Cells |
EP3925668A4 (de) | 2019-02-13 | 2022-11-09 | Sumitomo Pharma Co., Ltd. | Hemiasterlinderivat mit cysteinrückstand |
JP2020132638A (ja) * | 2019-02-13 | 2020-08-31 | 大日本住友製薬株式会社 | ヘミアスタリン誘導体を含む抗体薬物複合体を含有する医薬 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2904512A1 (de) * | 1979-02-07 | 1980-08-28 | Troponwerke Gmbh & Co Kg | Dehydropeptide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
NZ194747A (en) * | 1979-08-29 | 1988-11-29 | Schering Ag | 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives |
US4820691A (en) | 1987-06-24 | 1989-04-11 | E. R. Squibb & Sons, Inc. | Amino acid 1,2-diketo derivatives as renin inhibitors |
US5081225A (en) * | 1989-02-09 | 1992-01-14 | E. R. Squibb & Sons, Inc. | Gram-positive and gram-negative antibacterial compounds from the microorganism, janthinobacterium lividum |
US5340802A (en) * | 1989-06-30 | 1994-08-23 | Abbott Laboratories | Peptide analog type-B CCK receptor ligands |
WO1991004040A1 (en) * | 1989-09-15 | 1991-04-04 | Biomeasure, Inc. | Treatment of colon cancer |
FR2681075B1 (fr) * | 1991-09-05 | 1994-09-16 | Commissariat Energie Atomique | Preparation enzymatique purifiee issue de chromobacterium violaceum, son procede d'obtention et son application a la production d'alpha,beta-dehydrotryptophanyl-peptides. |
WO1993017701A1 (en) * | 1992-03-12 | 1993-09-16 | The Administrators Of The Tulane Educational Fund | Endothelin receptor-binding peptides |
US5721250A (en) * | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5661175A (en) * | 1995-06-20 | 1997-08-26 | Kashman; Yoel | Hemiasterlin and geodiamolide TA |
US7064211B2 (en) * | 2002-03-22 | 2006-06-20 | Eisai Co., Ltd. | Hemiasterlin derivatives and uses thereof |
-
1995
- 1995-04-20 GB GBGB9508195.6A patent/GB9508195D0/en active Pending
-
1996
- 1996-04-22 WO PCT/GB1996/000942 patent/WO1996033211A1/en active IP Right Grant
- 1996-04-22 AU AU53416/96A patent/AU5341696A/en not_active Abandoned
- 1996-04-22 DE DE69631141T patent/DE69631141T2/de not_active Expired - Lifetime
- 1996-04-22 US US08/930,584 patent/US6153590A/en not_active Expired - Lifetime
- 1996-04-22 JP JP53156496A patent/JP4008493B2/ja not_active Expired - Lifetime
- 1996-04-22 DK DK96910116T patent/DK0839154T3/da active
- 1996-04-22 EP EP96910116A patent/EP0839154B1/de not_active Expired - Lifetime
- 1996-04-22 AT AT96910116T patent/ATE256698T1/de not_active IP Right Cessation
- 1996-04-22 ES ES96910116T patent/ES2213173T3/es not_active Expired - Lifetime
- 1996-04-22 CA CA2220021A patent/CA2220021C/en not_active Expired - Lifetime
- 1996-04-22 PT PT96910116T patent/PT839154E/pt unknown
-
2000
- 2000-06-14 US US09/593,417 patent/US6870028B1/en not_active Expired - Fee Related
-
2005
- 2005-01-14 US US11/034,922 patent/US7410951B2/en not_active Expired - Fee Related
-
2006
- 2006-08-14 JP JP2006221150A patent/JP4006466B2/ja not_active Expired - Lifetime
-
2008
- 2008-07-21 US US12/176,716 patent/US7772397B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69631141T2 (de) | 2004-09-30 |
CA2220021A1 (en) | 1996-10-24 |
US6870028B1 (en) | 2005-03-22 |
US7772397B2 (en) | 2010-08-10 |
CA2220021C (en) | 2012-06-26 |
AU5341696A (en) | 1996-11-07 |
JPH11505211A (ja) | 1999-05-18 |
EP0839154B1 (de) | 2003-12-17 |
JP2007031441A (ja) | 2007-02-08 |
US20090088573A1 (en) | 2009-04-02 |
DK0839154T3 (da) | 2004-04-19 |
EP0839154A1 (de) | 1998-05-06 |
JP4006466B2 (ja) | 2007-11-14 |
ES2213173T3 (es) | 2004-08-16 |
PT839154E (pt) | 2004-05-31 |
JP4008493B2 (ja) | 2007-11-14 |
ATE256698T1 (de) | 2004-01-15 |
US7410951B2 (en) | 2008-08-12 |
US20050171137A1 (en) | 2005-08-04 |
GB9508195D0 (en) | 1995-06-07 |
WO1996033211A1 (en) | 1996-10-24 |
US6153590A (en) | 2000-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE256698T1 (de) | Biologisch aktive peptide und ihre zubereitungen und verwendungen | |
NL350077I1 (nl) | Cyprosulfamide | |
CY1107628T1 (el) | Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων | |
TR199800012T1 (xx) | Piroloprimidinler ve preparasyon i�in tatbikler. | |
ATE271058T1 (de) | Mycophenol bisphosponatverbindungen | |
BR0116452A (pt) | Composto, composição farmacêutica, uso de um composto | |
ATE368054T1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
DE69724811D1 (de) | Pentafluorobenzensulfonamide und analoge | |
PT765152E (pt) | Estimulacao do crescimento capilar por complexos de peptido-cobre | |
FI970810A0 (fi) | Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja | |
DE69938786D1 (de) | Die verwendung von peptiden von il-2 und peptid-derivaten als therapeutische wirkstoffe | |
ATE413179T1 (de) | Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden | |
BR0014355A (pt) | Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva | |
TR199800623T2 (xx) | Yeni amino asit t�revleri, m�stahzarlar� ve kullan�mlar�. | |
HUP9800731A2 (hu) | Eljárás ivarsejt osztódás stimulálására | |
DE69924292D1 (de) | Pyrazol verbindungen und ihre verwendung | |
AR021695A1 (es) | 4,5-pirazinoxindoles, composicion farmaceutica y uso | |
DE69636285D1 (de) | ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF | |
TR199900661T2 (xx) | Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m� | |
SE0003476D0 (sv) | Compounds | |
DE69612056D1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
ATE414100T1 (de) | Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen | |
TR199900087T2 (xx) | Alfo-amino asit amitleri, bunlar�n haz�rlanmas� ve terapik kullan�mlar�. | |
DE60019725D1 (de) | Verwendung eines mit dem peptid "elagigiltv" assoziierten enterobakterien-proteins ompa zur behandlung von melanomen | |
NZ504614A (en) | Echinocandin derivatives and application as anti-fungal agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |